Company: TVRD
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001104659-25-054853
Chunk: 424

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 424
---
 made to employees and non-employee consultants generally vest as to 25% on the first anniversary of the date of grant and the balance ratably over the next 36 monthsand subsequent grants vest monthly over a period of four yearsfrom the grant date. Stock options initially granted to members of the Company’s Board of Directors vest over a period of three yearsin equal quarterly installments from the date of the grant, subject to the option holder’s continued service as a director through such date. Subsequent grants to directors that are made automatically at Annual Meetings of Stockholders vest fully on the earlier of the first anniversary of the date of grant and the next Annual Meeting of Stockholders. The Plan administrator determines the term of Stock Awards granted under the 2014 Plan up to a maximum of ten years. The aggregate number of shares of the Company’s common stock reserved for issuance under the 2014 Plan has automatically increased on January 1 of each year, beginning on January 1, 2015 and continued to increase on January 1 of each year through and including January 1, 2024, by 3% of the total number of shares of the Company’s capital stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares determined by the Company’s Board of Directors. On January 1, 2024, the aggregate number of shares of common stock that may be issued pursuant to Stock Awards under the 2014 Plan automatically increased from 338,973to 384,373. The maximum number of shares that may be issued pursuant to the exercise of incentive stock options under the 2014 Plan is 833,333shares. Restricted Stock Units Under the 2014 Plan, the Company granted 25,108restricted stock units, 16,699restricted stock units, and 13,172restricted stock units for the years ended December 31, 2024, 2023 and 2022, respectively. Norestricted stock units were granted under the 2019 Inducement Plan during the years ended December 31, 2024, 2023 and 2022. The weighted average grant date fair value per share of restricted stock units granted to employees and non-employee members of the Company’s Board of Directors during the years ended December 31, 2024, 2023 and 2022 were $ 23.76, $ 281.16, and $ 363.60, respectively. As of December 31, 2024